3SBio
(OTC) TRSBF
3SBio Financials at a Glance
Market Cap
$6.52B
Revenue (TTM)
$17.50B
Net Income (TTM)
$4.02B
EPS (TTM)
$0.13
P/E Ratio
19.01
Dividend
$0.00
Beta (Volatility)
-0.07 (Low)
Dividend
$0.00
Beta (Volatility)
-0.07 (Low)
Price
$2.61
Volume
700
Open
$2.61
Price
$2.61
Volume
700
Open
$2.61
Previous Close
$2.61
Daily Range
$2.61 - $2.61
52-Week Range
$0.83 - $4.74
Dividend
$0.00
Beta (Volatility)
-0.07 (Low)
Price
$2.61
Volume
700
Open
$2.61
Previous Close
$2.61
Daily Range
$2.61 - $2.61
52-Week Range
$0.83 - $4.74
TRSBF News
TRSBF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 3SBio
Industry
Biotechnology
Sector
Health CareEmployees
6,109
CEO
Jing Lou, PhD, EMBA
Website
www.3sbio.comHeadquarters
Shenyang, 110027, CN
TRSBF Financials
Key Financial Metrics (TTM)
Gross Margin
85%
Operating Margin
26%
Net Income Margin
26%
Return on Equity
15%
Return on Capital
12%
Return on Assets
10%
Earnings Yield
5.26%
Dividend Yield
0.00%
Payout Ratio
23.53%
Stock Overview
Market Cap
$6.52B
Shares Outstanding
2.50B
Volume
700
Short Interest
0.00%
Avg. Volume
471.148
Financials (TTM)
Gross Profit
$7.83B
Operating Income
$2.73B
EBITDA
$3.30B
Operating Cash Flow
$3.20B
Capital Expenditure
$963.24M
Free Cash Flow
$2.24B
Cash & ST Invst.
$5.79B
Total Debt
$3.55B
3SBio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.36B
+15.1%
Gross Profit
$3.72B
+16.1%
Gross Margin
85.31%
N/A
Market Cap
$6.52B
N/A
Market Cap/Employee
$1.17M
N/A
Employees
5,577
N/A
Net Income
$1.36B
+38.5%
EBITDA
$1.44B
-1.8%
Quarterly Fundamentals
Net Cash
$4.59B
+169.8%
Accounts Receivable
$1.49B
+11.4%
Inventory
$902.82M
+22.0%
Long Term Debt
$59.02M
-98.0%
Short Term Debt
$1.81B
-9.8%
Return on Assets
9.90%
N/A
Return on Invested Capital
12.18%
N/A
Free Cash Flow
$0.00
-100.0%
Operating Cash Flow
$0.00
-100.0%